Guardian Pharmacy Services
GRDN on NYSE. Guardian Pharmacy Services sells pharmacy services and drugs to care homes and their residents. Market value $412m.
Price checks use the past 12 months to June 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Not a fit for our list right now
Why it could be worth it
What to watch out for
See Everyday goods stocks that passed both tests
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $3.33 of spare cash last year. A savings account pays about $4.
You pay 29.9 years of operating profit for the business. The average large US company costs around 18.
The filings do not give us enough to work this out.
Quality score: not known. Price score: 32 of 100. Our list needs 70 on quality and 60 on price.
$41.20 a share, 78% above its 1-year low
Over the past year the price has ranged from $23.14 to $48.33.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
| Revenue | |
| Revenue | $1.4bn |
| Operating margin | |
| Operating margin | 5.0% |
| Debt to equity | |
| Debt to equity | 0.03 |
| Shares outstanding | |
| Shares outstanding | n/a |
Health checks
- Free cash flow positive1 of 1 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)Not enough data
- Profit backed by cash (accruals)Not enough data
- Debt0.03× equity
- Revenue growth, five yearsUnknown
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $352 million last quarter, up 2% on a year ago.
- Profit: $22 million, up 142% on a year ago.
| Quarter to | Amount |
|---|---|
| September 2024 | $314m |
| March 2025 | $329m |
| June 2025 | $344m |
| September 2025 | $377m |
| December 2025 | $398m |
| March 2026 | $337m |
| June 2026 | $352m |
| Quarter to | Amount |
|---|---|
| September 2024 | -$122m |
| March 2025 | $9m |
| June 2025 | $9m |
| September 2025 | $10m |
| December 2025 | $21m |
| March 2026 | $13m |
| June 2026 | $22m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 11 March 2026
- Next quarterly (estimated, 10-Q)
- 5 November 2026
Who owns it
3 long-term investors we follow own it, unchanged from 3 last quarter. 189 funds in all.
- Royce & AssociatesChuck Royce
- Value
- $4m
- Share of fund
- <0.1%
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| Boston PartnersBoston Partners team | $41m | <0.1% | Cut |
| Royce & AssociatesChuck Royce | $4m | <0.1% | |
| Gotham Asset ManagementJoel Greenblatt | $261,897 | <0.1% | Cut |
Largest holders overall
- FMR$136mAdded
- Wellington Management Group LLP$72mCut
- BlackRock$66mCut
- Vanguard Capital Management$58mAdded
- Woodline Partners LP$55m
- Valiant Capital Management, L.P.$50m
- T. Rowe Price Investment Management$47mAdded
- Boston Partners$41mCut
- Franklin Resources$40m
- TimesSquare Capital Management$40mCut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
5 investors own more than 5%.
- Thomas J. Salentine, Jr.Insider or founderat least 26.4%+5.1 pts(filed with 8 related holders)Since 27 September 2026
- FMR LLCPassive investorat least 6.5%(filed with 1 related holder)Since 31 March 2026
- Alyeska Investment Group, L.P.Passive investorat least 4.7%(filed with 2 related holders)Since 31 December 2024
- Wellington Management Group LLPPassive investorat least 3.1%−1.9 pts(filed with 2 related holders)Since 31 December 2025
- J. Goldman & Co LPPassive investorat least 2.9%(filed with 2 related holders)Since 30 September 2025
- Woodline Partners LPPassive investorSold down below 5%Since 31 December 2024
- Franklin Resources, Inc.Passive investorSold down below 5%Since 30 June 2025
- The Vanguard GroupPassive investorSold down below 5%Since 30 June 2025
- BlackRock, Inc.Passive investorSold down below 5%Since 31 December 2025
- TIAA-CREF Investment Management, LLCPassive investorSold down below 5%Since 30 May 2025
- Clearbridge Investments, LLCPassive investorSold down below 5%Since 30 June 2025
- Ophir Asset Management Pty LtdPassive investorSold down below 5%Since 5 December 2024
- Nuveen Asset Management, LLCPassive investorSold down below 5%Since 30 May 2025
- BROWN INVESTMENT ADVISORY & TRUST COPassive investorSold down below 5%Since 31 December 2025
- Teachers Advisors, LLCPassive investorSold down below 5%Since 30 May 2025
| Holder | Stake | Since | |
|---|---|---|---|
Thomas J. Salentine, Jr. Insider or founder | at least 26.4%+5.1 pts (filed with 8 related holders) | 27 September 2026 | |
FMR LLC Passive investor | at least 6.5% (filed with 1 related holder) | 31 March 2026 | |
Alyeska Investment Group, L.P. Passive investor | at least 4.7% (filed with 2 related holders) | 31 December 2024 | |
Wellington Management Group LLP Passive investor | at least 3.1%−1.9 pts (filed with 2 related holders) | 31 December 2025 | |
J. Goldman & Co LP Passive investor | at least 2.9% (filed with 2 related holders) | 30 September 2025 | |
Woodline Partners LP Passive investor | Sold down below 5% | 31 December 2024 | |
Franklin Resources, Inc. Passive investor | Sold down below 5% | 30 June 2025 | |
The Vanguard Group Passive investor | Sold down below 5% | 30 June 2025 | |
BlackRock, Inc. Passive investor | Sold down below 5% | 31 December 2025 | |
TIAA-CREF Investment Management, LLC Passive investor | Sold down below 5% | 30 May 2025 | |
Clearbridge Investments, LLC Passive investor | Sold down below 5% | 30 June 2025 | |
Ophir Asset Management Pty Ltd Passive investor | Sold down below 5% | 5 December 2024 | |
Nuveen Asset Management, LLC Passive investor | Sold down below 5% | 30 May 2025 | |
BROWN INVESTMENT ADVISORY & TRUST CO Passive investor | Sold down below 5% | 31 December 2025 | |
Teachers Advisors, LLC Passive investor | Sold down below 5% | 30 May 2025 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 1 insider bought $99,786 of shares on the open market. 6 sold $280m.
- Morris David KSee Remarks, DirectorSold
- Date
- 20 March 2026
- Shares
- 187,855
- Price
- $29.68
- Value
- $6m
- Burke FredSee Remarks, DirectorSold
- Date
- 20 March 2026
- Shares
- 671,432
- Price
- $29.68
- Value
- $20m
- Salentine Thomas J JrDirectorSold
- Date
- 20 March 2026
- Shares
- 3,570,677
- Price
- $29.68
- Value
- $106m
- Ackerman JohnDirectorSold
- Date
- 20 March 2026
- Shares
- 1,103,364
- Price
- $29.68
- Value
- $33m
- BINDLEY WILLIAM EDirectorSold
- Date
- 20 March 2026
- Shares
- 3,570,677
- Price
- $29.68
- Value
- $106m
- Forbes KendallSee RemarksSold
- Date
- 20 March 2026
- Shares
- 346,672
- Price
- $29.68
- Value
- $10m
- COSLER STEVEN DDirectorBought
- Date
- 3 December 2025
- Shares
- 3,370
- Price
- $29.61
- Value
- $99,786
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 20 March 2026 | Morris David K See Remarks, Director | Sold | 187,855 | $29.68 | $6m |
| 20 March 2026 | Burke Fred See Remarks, Director | Sold | 671,432 | $29.68 | $20m |
| 20 March 2026 | Salentine Thomas J Jr Director | Sold | 3,570,677 | $29.68 | $106m |
| 20 March 2026 | Ackerman John Director | Sold | 1,103,364 | $29.68 | $33m |
| 20 March 2026 | BINDLEY WILLIAM E Director | Sold | 3,570,677 | $29.68 | $106m |
| 20 March 2026 | Forbes Kendall See Remarks | Sold | 346,672 | $29.68 | $10m |
| 3 December 2025 | COSLER STEVEN D Director | Bought | 3,370 | $29.61 | $99,786 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the warning signs we check for were found.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 11 Mar 2026, plus the 10-Q filed 6 Aug 2026 and 7 later 8-Ks.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
- It isn't cheap on profits: 29.9× operating profit.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.